Skip to content

Role of homoeopathic medicines in cases of diabetes mellitus type 2

An experimental randomised prospective study to evaluate the role of constitutional medicines in cases of diabetes mellitus type 2 - Nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/079787
Enrollment
40
Registered
2025-01-30
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Individualized homoeopathic medicines: Individualized homoeopathic medicines selected by case taking 30 200 1m 10m potencies will be given to the patient according to patients succeptib

Sponsors

Rajkot homoeopathic medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients of both sexes and age group between 35-65 years of both the sexes will be considered. 2 All socio-economical classes will be considered. 3 Patients having HbA1c less than or equal to 8%. 4 Pre-diagnosed or recently diagnosed cases which are under any system of treatment, but yet not having relief or improvement and willing to take Homoeopathy.

Exclusion criteria

Exclusion criteria: 1 Patients with advance and irreversible pathological conditions or any complications with diabetes mellitus type 2 Cases of diabetes insipidus. 3 Cases having more than 8% HbA1c. 4 Patients of less than 35 years age & more than 65 years of age of both the sexes.

Design outcomes

Primary

MeasureTime frame
Patients of diabetes mellitus type 2 will be benefited by individual constitution homoeopathic medicines Timepoint: This out come will be achieved 24 weeks

Secondary

MeasureTime frame
To manage the cases of diabetes mellitus type 2 with Homoeopathic medicines • To evaluate role of homoeopathic constitutional medicines in cases of diabetes mellitus type 2.Timepoint: The out come will be assessed 24 weeks

Countries

India

Contacts

Public ContactDr Priyanka j Shroff

Rajkot homoeopathic medical College

priyanka.shroff20492@paruluniversity.ac.in9898930311

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026